East Campus Gynecology Department

I. Department scale:

The Department of Gynecology at the East Campus of Qingdao Municipal Hospital has a strong technical team and advanced medical equipment, integrating clinical care, scientific research, and teaching. It has successively been approved as the Qingdao Specialty Department for Gynecologic Minimally Invasive Care, a Qingdao Class B Key Discipline, a Shandong Provincial Clinical Key Specialty, a Shandong Provincial Standardized Training Base for Gynecologic Endoscopy, and a National Standardized Training Base for Resident Physicians. Since its establishment, the Department of Gynecology at the East Campus has focused on gynecologic minimally invasive surgery and has reached an advanced level within the province and nationally in the minimally invasive and comprehensive treatment of benign and malignant gynecologic tumors; surgical treatment of pelvic organ prolapse disorders and pelvic floor rehabilitation treatment; diagnosis and treatment of cervical lesions; diagnosis and treatment of intrauterine diseases; and fertility-preserving and organ-function-preserving surgical treatment for various benign and malignant gynecologic tumors. It is a highly influential regional center for the diagnosis and treatment of difficult and severe gynecologic conditions and a base for safeguarding women's health. The department receives approximately 80,000 outpatient visits annually, has approximately 3,500 inpatient admissions annually on average, and performs more than 3,000 operations on average each year. The department currently has 43 beds, with 58 beds actually open, and 46 medical and nursing staff, including 25 physicians and 21 nurses; there are 10 chief physicians and 6 deputy chief physicians, including 9 doctors and 3 postdoctoral fellows. The department has a well-developed talent pipeline. All staff have a solid professional foundation and extensive clinical experience; the team's overall structure of professional titles and educational backgrounds is well balanced, with orderly succession among senior, middle-aged, and young staff.

Professor Xia Baoguo, the academic leader, is a renowned gynecology expert in China. He serves in several important academic positions, including member of the Single-Port Laparoscopy Group of the Micro-Invasive and Non-Invasive Surgery Branch of the Chinese Medical Doctor Association; chairman of the Ovarian Cancer Multidisciplinary Diagnosis and Treatment Branch of the Shandong Society of Translational Medicine; deputy chair of the Gynecologic Laparoscopic Physicians Branch of the Shandong Medical Doctor Association; deputy chair of the Gynecologic Oncology Branch, deputy chair of the Endometriosis Branch, and deputy chair of the Cervical Cancer Prevention and Treatment Special Committee of the Shandong Research-Oriented Hospital Association, among others. He has been engaged in gynecologic clinical practice, research, and teaching for more than 20 years, with extensive work in the research fields of gynecologic oncology, minimally invasive gynecology, and pelvic-floor repair. He is skilled in laparoscopic, hysteroscopic, single-port laparoscopic, and Da Vinci robotic minimally invasive surgery for various benign and malignant gynecologic tumors. He has conducted particularly in-depth research on minimally invasive and comprehensive treatment of gynecologic malignant tumors, is adept at managing various difficult and complex gynecologic diseases, and is skilled in radical surgery for cervical cancer, endometrial cancer, ovarian cancer, vulvar cancer, and other gynecologic malignant tumors; pelvic exenteration for advanced gynecologic malignant tumors; resection and reconstruction of metastatic organs; and adjuvant radiotherapy, chemotherapy, and targeted therapy. In 2016, he began using “autologous tissue repair” to treat various pelvic-organ prolapse diseases, such as uterine and vaginal prolapse, avoiding the various complications caused by mesh surgery and achieving good clinical results. At the beginning of 2017, he was the first in Qingdao to carry out less traumatic single-port laparoscopic surgery and VNOTES surgery (transvaginal single-port laparoscopy); while being micro-invasive and non-invasive, these procedures also provide cosmetic benefits and have received unanimous praise from the majority of patients. At the end of 2018, he was the first in the province to perform laparoscopic radical surgery for cervical cancer and endometrial cancer without uterine manipulation; while remaining minimally invasive, this better implemented the no-tumor-seeding principle. Since 2019, he has performed various benign and malignant gynecologic tumor surgeries with the Da Vinci robot. Through binocular naked-eye high-definition 3D images magnified 10 times and wristed surgical instruments with 7 degrees of freedom, the surgical anatomy is clearer, operations are more precise, blood loss is lower, operating time is shorter, and recovery is faster. He is skilled in various surgeries for endometriosis and deep DIE, uterine fibroids, adenomyosis, and fertility- and organ-function-preserving surgery for early malignant tumors. He has led and participated in multiple national-, provincial-, and municipal-level scientific research projects, attended academic conferences inside and outside the province many times and delivered lectures and surgical video demonstrations at major sessions, participated in formulating multiple industry diagnosis and treatment consensuses, and has profound academic attainments. He comprehensively leads the department’s discipline development, technological innovation, and talent cultivation.

The department is grounded in the hospital’s development positioning as a high-level Grade III Class A hospital, with “precision diagnosis and treatment, minimally invasive leadership, full-cycle healthcare, and research translation empowerment” as its discipline development direction, focusing on the treatment of difficult and critical gynecological conditions and the promotion of cutting-edge technologies. The department’s hardware configuration is benchmarked against leading domestic standards, and is equipped with high-definition optical electronic colposcopes, LEEP knives, laser therapy devices, pelvic floor rehabilitation therapy devices, visual abortion equipment, vaginal color Doppler ultrasound, an Olympus 4K ultra-high-definition laparoscopic system, a hysteroscopy system, single-port laparoscopic equipment, and other high-end medical equipment from China and abroad, including the 4th-generation da Vinci robotic system XI. The department has achieved precision throughout the entire process of gynecological disease screening, diagnosis, treatment, and rehabilitation, providing solid hardware support for high-level clinical diagnosis and treatment.

II. Scope of diagnosis and treatment:

1. Surgery for benign gynecological tumors: such as laparoscopic myomectomy, ovarian tumor stripping, adnexectomy, hysterectomy, etc.; 2. Surgery for malignant gynecological tumors: such as comprehensive staging surgery for early-stage endometrial cancer, cervical cancer, ovarian cancer, and fallopian tube cancer under laparoscopy, radical vulvectomy for vulvar cancer + laparoscopic inguinal lymph node dissection, and laparoscopic radical surgery for vaginal cancer; radical surgery for advanced ovarian cancer, fallopian tube cancer, and endometrial cancer, resection and reconstruction of metastatic organs, pelvic exenteration, as well as postoperative adjuvant treatment and targeted therapy; 3. Fertility- and organ-preserving surgery for benign gynecological tumors and early-stage malignant tumors; 4. Pelvic organ prolapse diseases: surgical treatment and pelvic floor rehabilitation for uterine prolapse, vaginal prolapse, stress urinary incontinence, old perineal lacerations, vaginal laxity, etc.; 5. Surgical treatment of various cervical, vaginal, and vulvar precancerous lesions and cancers; 6. Surgical treatment, medication treatment, and long-term postoperative management of endometriosis, adenomyosis, abdominal wall endometriosis, deep DIE, etc.; 7. Treatment of intrauterine diseases: hysteroscopic surgery for endometrial polyps, submucosal uterine fibroids, endometrial proliferative diseases, endometrial precancerous lesions, intrauterine adhesions, uterine septum, abnormal uterine bleeding, etc.; 8. Reproductive endocrine diseases: surgical treatment of female infertility, tubal irrigation or imaging, tubal recanalization, cervical internal os incompetence, etc.; endocrine treatment of diseases such as menstrual disorders, abnormal uterine bleeding, amenorrhea, polycystic ovary syndrome, premature ovarian failure, and menopausal syndrome; 9. Pregnancy-related diseases: diagnosis and treatment of early-pregnancy miscarriage, threatened miscarriage, surgical and conservative treatment of ectopic pregnancy, surgical treatment of scar pregnancy, hydatidiform mole, invasive hydatidiform mole, choriocarcinoma, and other gestational trophoblastic diseases, etc.; 10. Family planning: IUD removal/insertion, induced abortion, medical abortion, missed abortion, ectopic intrauterine contraceptive device, etc.; 11. Gynecological inflammatory diseases: such as vaginitis, cervical inflammatory diseases, pelvic inflammatory disease, adnexitis, HPV infection, etc.

III: Departmental Features and Technical Advantages:

Since its establishment, the Gynecology Department of the East Hospital has been committed to treating women's health conditions, with minimally invasive surgery as its specialty. In 2004, it took the lead in the island city in performing a series of novel vaginal surgeries, such as vaginal hysterectomy, subtotal hysterectomy, transvaginal myomectomy, and transvaginal ovarian cystectomy, among others. These procedures offer the advantages of no abdominal incision or scar and less trauma. It also took the lead in Qingdao in performing laparoscopic minimally invasive surgical treatment for various benign and malignant gynecologic tumors, as well as various hysteroscopic surgeries, and was approved as a Qingdao Specialty Department for Gynecologic Minimally Invasive Surgery. At the beginning of 2017, it took the lead in Qingdao in performing less traumatic transumbilical single-port laparoscopic gynecologic surgery and transvaginal single-port laparoscopic surgery (VNOTES), achieving a micro-traumatic, nearly noninvasive effect. In December 2018, it took the lead in Qingdao in performing uterine-manipulator-free laparoscopic radical surgery for cervical cancer and comprehensive staging surgery for endometrial cancer without a uterine manipulator; while being minimally invasive, these procedures are more consistent with the no-touch tumor principle. In 2019, it took the lead in Qingdao in performing gynecologic malignant tumor surgery with a fourth-generation da Vinci robot. Compared with traditional laparoscopic surgery, it is more flexible, precise, and stable, achieving good clinical results and enabling the development of gynecologic surgery from minimally invasive to nearly noninvasive procedures, and from nearly noninvasive to intelligent surgery. In recent years, the department has joined with the General Surgery, Urology, Hepatobiliary Surgery, Anesthesiology, ICU, and other sister departments to establish a gynecologic oncology MDT diagnosis and treatment platform. It has accumulated extensive clinical experience in fertility-preserving surgery for early gynecologic malignant tumors, comprehensive staging surgery for early malignant tumors, radical surgery for advanced malignant tumors, postoperative adjuvant radiotherapy and chemotherapy, and targeted and immunotherapy, achieving good clinical outcomes. This has significantly improved patients' tumor-free survival rate, survival rate, and quality of life. At present, the department's minimally invasive techniques, surgery and comprehensive treatment of gynecologic malignant tumors, whole-course management, and surgical treatment of female pelvic organ prolapse and other conditions have all reached leading levels within the province and nationwide.

After years of dedicated cultivation and development, the department has established seven stable and mature core specialty areas: minimally invasive gynecology, gynecologic oncology, cervical lesions, pelvic floor dysfunction disorders, reproductive endocrinology, intrauterine diseases, and endometriosis. Its specialized strengths are prominent, and its brand recognition is high. The department serves as the chair institution of the Ovarian Cancer Multidisciplinary Diagnosis and Treatment Branch of the Shandong Society of Translational Medicine and is the regional leading institution for standardized multidisciplinary diagnosis and treatment of ovarian cancer. It leads the promotion of regional standards for ovarian cancer diagnosis and treatment, consultations on difficult cases, technical collaboration, and academic exchange, greatly improving the region’s comprehensive treatment capacity for gynecologic malignant tumors. The department implements quality-control management throughout the entire process, with standardized and regulated diagnosis and treatment procedures. In recent years, a number of new technologies have filled gaps in the region, the capacity for treating difficult and critically ill patients has continued to improve, and its regional leadership and outreach capacity have increased significantly.

Subspecialty introduction:

1. Gynecologic Oncology Subspecialty: Our department is the institution chairing the Ovarian Cancer Multidisciplinary Diagnosis and Treatment Branch of the Shandong Society for Translational Medicine. It is the earliest hospital in Qingdao to perform laparoscopic radical surgery for gynecologic malignancies, and specializes in surgical treatment, adjuvant radiotherapy and chemotherapy, and targeted maintenance therapy for all types of gynecologic malignancies. We now comprehensively perform radical or comprehensive staging surgery for early-stage endometrial cancer, early-stage cervical cancer, and ovarian cancer via open abdominal surgery, laparoscopy, single-port laparoscopy, and the da Vinci robot; among these, para-aortic lymph node dissection has reached the level of the renal vessels. We perform surgeries for vulvar and vaginal malignancies, including radical vulvectomy plus laparoscopic inguinal lymph node dissection for vulvar cancer, and laparoscopic total vaginectomy plus pelvic and abdominal lymph node dissection for vaginal cancer. For advanced ovarian or fallopian tube cancer, we perform carpet-like cytoreductive surgery; together with the Departments of General Surgery, Urology, Hepatobiliary Surgery, Vascular Surgery, Anesthesiology, and others, we have established an MDT multidisciplinary collaborative diagnosis and treatment platform and perform total, anterior, middle, and posterior pelvic exenteration, as well as resection and reconstruction of metastatic organs. We have introduced genetic testing technology for gynecologic malignancies and carry out targeted and immunotherapies, providing patients with the latest and more precise treatment. We emphasize standardized, individualized, and human-centered long-term comprehensive management of cancer treatment, integrating surgery, chemotherapy, radiotherapy, and targeted maintenance therapy to reduce tumor recurrence and continuously improve patients’ overall survival and quality of life.

2. Gynecologic Endoscopy and Robotic Subspecialty: Our department is a specialized gynecologic minimally invasive unit in Qingdao, a standardized gynecologic endoscopy training base in Shandong Province, and a member institution of the Shandong Provincial Gynecologic Endoscopy Specialty Alliance. Gynecologic minimally invasive surgery is our department’s signature service. We currently perform a full range of minimally invasive procedures under multi-port laparoscopy for various benign and malignant gynecologic tumors. At present, 95% of surgeries can be completed using minimally invasive techniques; the technology is mature and advanced and has received unanimous recognition from the people of Qingdao. In early 2017, we took the lead in Qingdao in performing the less traumatic transumbilical single-port laparoscopic surgery and transvaginal single-port laparoscopic surgery (VNOTES surgery). Compared with traditional laparoscopic surgery, these procedures cause less trauma, enable faster recovery, involve smaller and more concealed incisions, better provide cosmetic benefits and protect patient privacy, and more closely conform to the concepts of minimally invasive treatment and enhanced recovery. They have received unanimous acclaim from the majority of patients, achieving the development from minimally invasive to nearly non-invasive surgery. This technology is currently at an advanced level within Shandong Province and across China. Over the past nearly 7 years, using da Vinci robotic surgery as a new breakthrough point, we have continuously advanced the development and innovation of intelligent gynecologic surgery and enhanced the department’s new competitiveness. Our department has now completed multiple robotic surgeries for benign and malignant gynecologic tumors, with good results. In the future, we will continue to vigorously perform various gynecologic surgeries with robotic assistance, bringing gynecologic surgery from the era of endoscopy into the era of robotic surgery and achieving the development of gynecologic surgery from minimally invasive treatment toward intelligent treatment.

3. Cervical Lesions Subspecialty: Cervical diseases are common and frequently occurring conditions that affect women's health. Cervical cancer in particular is one of the most common malignant tumors in women, seriously affecting women's reproductive health and even their lives. To achieve the grand goal of a Healthy China by 2030 and in response to the action plan proposed by the World Health Organization to completely eliminate cervical cancer by 2069, our department has established an outpatient clinic for cervical lesions and an outpatient clinic for cervical disease prevention. We have changed the cervical disease care model from one centered on screening and treatment to one centered on the integration of prevention, screening, and treatment, with the aim of achieving the work objectives of early prevention, early diagnosis, early treatment, and early rehabilitation of cervical diseases. Our department has established a long-term cooperative relationship with the team of Professor Sui Long from the Obstetrics and Gynecology Hospital Affiliated with Fudan University. We have successively and systematically sent senior gynecologists to well-known cervical disease diagnosis and treatment centers in China and abroad, including the Obstetrics and Gynecology Hospital Affiliated with Fudan University and Tongji Hospital of Huazhong University of Science and Technology, for further training or academic exchange, laying a solid foundation for the cervical disease subspecialty. The department has a professional team of colposcopists and undertakes cervical cancer screening as part of Qingdao Laoshan District's annual screening for the two major cancers. Each year, we identify large numbers of patients with HPV infection, cervical precancerous lesions, and cervical cancer through screening. We have carried out physical treatment, LEEP treatment, excision of precancerous lesions, cervical conization, and other surgical treatments for precancerous lesions of the cervix, vagina, and vulva. For patients with early-stage cervical cancer who desire fertility, we perform fertility-sparing radical trachelectomy plus sentinel lymph node excision. For patients with early-stage cervical cancer who do not desire fertility, we routinely perform open, laparoscopic, or da Vinci robotic radical hysterectomy plus pelvic and abdominal lymph node dissection, among other procedures.

4. Pelvic floor dysfunction diseases and pelvic floor rehabilitation subspecialty: Pelvic floor dysfunction diseases have become the fourth leading chronic disease among women. Our department is a member institution of the Shandong Provincial Pelvic Floor Disease Specialist Alliance. We currently routinely perform pelvic floor assessment and screening for pelvic floor dysfunction diseases, various pelvic floor rehabilitation treatments, and surgical treatment, integrating screening, surgical treatment, and pelvic floor rehabilitation treatment, and continuously improving the quality of life and health index of women. Our department was the first in Qingdao to perform mesh-based total, anterior, and posterior pelvic floor repair, laparoscopic vaginal/uterine sacral fixation, iliopubic ligament suspension, TVT-0, laparoscopic BURCH surgery, and other treatments for various pelvic organ prolapse diseases, achieving good clinical results. In response to various complications caused by mesh surgery, over the past 10 years we have carried out a series of procedures using autologous tissue repair to treat various pelvic organ prolapse diseases, such as laparoscopic high uterosacral ligament suspension, laparoscopic uterine abdominal wall suspension, transvaginal fixation of the vaginal vault/uterus to the sacrospinous ligament, laparoscopic uterosacral ligament reconstruction + modified vaginal/uterine sacral promontory fixation, and others. While achieving good clinical efficacy, these procedures have significantly reduced the various complications caused by mesh surgery.

5. Subspecialty of Reproductive Surgery and Reproductive Endocrinology: For patients with infertility, routinely performs various infertility-related examinations and etiological treatments, such as tubal hydrotubation, hysterosalpingography, hysteroscopic resection of endometrial polyps, resection of a septate uterus, hysteroscopic adhesiolysis, and other treatments for various intrauterine diseases; laparoscopic tubal reconstructive repair, reconstructive repair of uterine malformations, and other laparoscopic and hysteroscopic surgeries for patients wishing to have children, striving to enable patients to conceive naturally. Laparoscopic cervical cerclage at the internal cervical os is performed for “cervical insufficiency” during the non-pregnant period; to date, many pregnant women have successfully conceived and delivered.

6. Subspecialty in intrauterine diseases: Hysteroscopic technology is the gold standard for observing lesions inside the uterine cavity and vagina, and for evaluating and treating lesions within the uterine cavity. The Department of Gynecology of our hospital has a complete professional technical team and advanced medical equipment; for the diagnosis and treatment of intrauterine diseases, it is equipped with the most advanced equipment currently available, such as multiple Olympus high-definition hysteroscopes, the IBS intrauterine tissue morcellation system, a cold-knife hysteroscopy system, outpatient hysteroscopes for uterine cavity examination, vaginal endoscopes, etc. The diseases that can be diagnosed and treated by our intrauterine disease subspecialty include: abnormal uterine bleeding; space-occupying lesions within the uterine cavity, such as endometrial polyps and submucosal uterine fibroids; abnormalities of intrauterine contraceptive devices and intrauterine foreign bodies; pregnancy-related diseases: retained products of conception, cornual pregnancy, cervical pregnancy, and cesarean scar pregnancy; intrauterine adhesions and uterine malformations: bicornuate uterus, uterine septum, oblique uterine septum, etc.; vaginal discharge and/or vaginal foreign bodies in young girls; surgical treatment of cesarean scar diverticulum; vaginal lesions: vaginal polyps, vaginal foreign bodies, longitudinal vaginal septum, vaginal endometriosis, etc.

7. Endometriosis subspecialty: includes minimally invasive surgical treatment, medical treatment, and long-term management of adenomyosis, ovarian chocolate cysts, and deep endometriosis. Particularly skilled in open and laparoscopic excision of adenomyosis lesions for adenomyosis requiring preservation of uterine organ function, partial hysterectomy preserving the ascending branches of the uterine arteries, and other procedures; skilled in the surgical treatment, medical treatment, and long-term management of various forms of deep infiltrating endometriosis, urinary tract endometriosis, and intestinal endometriosis.

IV. Scientific Research and Teaching

The department is committed to the coordinated, high-quality development of clinical care, research, and education. Relying on the platform of a Grade III Class A teaching hospital, it undertakes the training of master's degree students, standardized training of resident physicians, and the teaching and supervision of interns and visiting physicians. The department has a comprehensive teaching system and, through diversified teaching methods such as teaching rounds, case discussions, practical skills training, specialized lectures, and reviews of difficult cases, strengthens young physicians' clinical reasoning and practical skills. It has been rated as an excellent teaching department multiple times.

In terms of scientific research, the department relies on the Ovarian Cancer MDT Chair Platform and focuses on hot areas such as translational research on gynecologic tumors, mechanisms underlying the outcomes of cervical lesions, optimization of minimally invasive techniques, and pelvic floor function restoration to carry out systematic scientific research. Over the past five years, it has undertaken 2 national-level multicenter clinical research projects, 3 Shandong Provincial Natural Science Foundation projects, and 5 municipal-level projects; it has published more than 20 papers in SCI-indexed and core journals and participated in the compilation of multiple medical monographs. The department regularly organizes and undertakes provincial- and municipal-level academic conferences on gynecologic tumors and minimally invasive techniques, actively promotes cutting-edge diagnostic and treatment concepts, and advances the overall technical level of gynecology in the region.

V. Talent Development

The department places great emphasis on building a talent echelon and has established a long-term talent development mechanism featuring tiered classification and targeted empowerment. It adheres to the training philosophy of “expert leadership, backbone support, and young talent development,” implements a mentor–protégé pairing and support system, and develops personalized training plans for medical and nursing personnel at different levels. It regularly selects young and middle-aged key personnel to undertake further training in minimally invasive techniques, gynecologic oncology MDT diagnosis and treatment, precision treatment of cervical lesions, pelvic floor rehabilitation, and other cutting-edge technologies at top domestic Grade A tertiary hospitals.

The department encourages medical personnel to pursue higher academic qualifications, engage in academic exchanges, participate in skills competitions, and pursue scientific research and innovation. Through routine professional learning, surgical case reviews, discussions of difficult cases, and skills assessments, it comprehensively hones the team’s clinical, research, and teaching capabilities. At present, the department has established a professional talent team with high levels of education, outstanding technical expertise, a well-structured talent pipeline, and strong potential for further development. Its young and middle-aged key personnel have become the backbone of the department’s clinical services, technological innovation, and disciplinary development, providing solid talent support for the department’s continued leadership in the region’s gynecology specialty and its high-quality development.

VI: Other content demonstrating the department’s technical capabilities and distinctive diagnostic and treatment features

To promote the development and innovation of regional gynecologic oncology and minimally invasive technologies, in recent years, relying on the platform of the Ovarian Cancer Multidisciplinary Diagnosis and Treatment Branch of the Shandong Society of Translational Medicine and the platform of Qingdao’s distinctive gynecologic minimally invasive specialty, the Puji Forum—Academic Symposium on New Advances in Gynecologic Oncology and Minimally Invasive Technologies has been held annually. Each conference has featured rich and varied content and has achieved complete success! Each congress has invited many leading figures and key experts in gynecologic oncology and minimally invasive medicine from within and outside the province to give lectures, covering both the latest internationally cutting-edge research findings and guideline updates, as well as clinical data based on large samples and multiple centers; both profound reflection on controversial issues and meticulous refinement of surgical details. Through multidimensional, in-depth discussions of multiple diseases, the conferences have comprehensively presented the academic landscape of gynecologic oncology and minimally invasive medicine, from standardized treatment to cutting-edge exploration, and have shown from multiple perspectives the surgical concepts and innovative exploration of precision, minimally invasive, and individualized care, providing abundant ideas and inspiration for clinical practice and technological innovation. The successful holding of the Puji Forum is an important measure for promoting regional gynecologic oncology diagnosis and treatment standards and gynecologic minimally invasive technologies to new heights. In the future, the Municipal Gynecology team will continue to rely on the multidisciplinary collaboration platform, deepen exchanges and cooperation with top medical institutions in China, stay grounded in clinical practice, cultivate the discipline deeply, and strive with perseverance; upholding the “Puji” spirit, it will continue to explore and pass the torch from one generation to the next, contribute greater strength to safeguarding women’s health, and contribute Municipal strength to promoting the high-quality development of gynecologic oncology and minimally invasive medicine throughout the province.

Editing time: 2026/9/21 13:43:31